Detalhe da pesquisa
1.
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.
Prostate
; 84(8): 747-755, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544345
2.
Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE).
Cancer
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340349
3.
Adherence With Oral Anticancer Therapies: Clinical Trial vs Real-world Experiences With a Focus on Prostate Cancer.
J Urol
; 209(3): 485-493, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472138
4.
A randomized comparison of group mindfulness and group cognitive behavioral therapy vs control for couples after prostate cancer with sexual dysfunction.
J Sex Med
; 20(3): 346-366, 2023 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763954
5.
Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?
Curr Opin Urol
; 33(5): 396-403, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497748
6.
Living with prostate cancer: a mixed-method evaluation of group therapy intervention to alleviate psychological distress in a Canadian setting.
Support Care Cancer
; 31(7): 398, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326757
7.
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Circulation
; 144(16): 1295-1307, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459214
8.
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.
Future Oncol
; 18(1): 35-45, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636627
9.
Cognitive skill training improves memory, function, and use of cognitive strategies in cancer survivors.
Support Care Cancer
; 30(1): 711-720, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34368888
10.
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
Lancet Oncol
; 22(9): 1250-1264, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388386
11.
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Prostate
; 81(16): 1382-1389, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516663
12.
Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data.
J Urol
; 205(2): 554-560, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090917
13.
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.
J Urol
; 206(5): 1147-1156, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503355
14.
The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data.
J Urol
; 203(4): 743-750, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31580749
15.
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.
Cancer
; 125(23): 4172-4180, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483485
16.
Germline and Somatic Mutations in Prostate Cancer for the Clinician.
J Natl Compr Canc Netw
; 17(5): 515-521, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085765
17.
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(5): 479-505, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085757
18.
Current recommendations for prostate cancer genetic testing: NCCN prostate guideline.
Can J Urol
; 26(5 Suppl 2): 34-37, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629426
19.
Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer.
Prostate
; 78(2): 121-127, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29105802
20.
Cardiovascular Disease and Androgen Axis-Targeted Drugs for Prostate Cancer.
N Engl J Med
; 382(23): 2257-2259, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469186